{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:14:54Z","timestamp":1752228894889},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11912-019-0794-2","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T09:00:36Z","timestamp":1553677236000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Central Nervous System Involvement of Natural Killer and T Cell Neoplasms"],"prefix":"10.1007","volume":"21","author":[{"given":"Ashley E.","family":"Aaroe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn S.","family":"Nevel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"issue":"20","key":"794_CR1","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375\u201390.","journal-title":"Blood"},{"issue":"21","key":"794_CR2","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1200\/JCO.2017.72.7602","volume":"35","author":"C Grommes","year":"2017","unstructured":"Grommes C, DeAngelis LM. Primary CNS lymphoma. J Clin Oncol. 2017;35(21):2410\u20138.","journal-title":"J Clin Oncol"},{"issue":"2","key":"794_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1200\/JCO.2003.09.139","volume":"21","author":"AJ Ferreri","year":"2003","unstructured":"Ferreri AJ, Blay JY, Reni M, Pasini F, Spina M, Ambrosetti A, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol. 2003;21(2):266\u201372.","journal-title":"J Clin Oncol"},{"issue":"48","key":"794_CR4","doi-asserted-by":"publisher","first-page":"28897","DOI":"10.18632\/oncotarget.25622","volume":"9","author":"D Chihara","year":"2018","unstructured":"Chihara D, Fowler NH, Oki Y, Fanale MA, Nastoupil LJ, Westin JR, et al. Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis. Oncotarget. 2018;9(48):28897\u2013902.","journal-title":"Oncotarget."},{"issue":"10","key":"794_CR5","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1200\/JCO.2005.07.109","volume":"23","author":"TN Shenkier","year":"2005","unstructured":"\u2022 Shenkier TN, Blay JY, O'Neill BP, Poortmans P, Thiel E, Jahnke K, et al. Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group. J Clin Oncol. 2005;23(10):2233\u20139 This is a large study on patients with primary CNS T cell lymphoma and describes outcome and general treatment regimens used in this patient population.","journal-title":"J Clin Oncol"},{"issue":"12","key":"794_CR6","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","volume":"39","author":"MP Menon","year":"2015","unstructured":"Menon MP, Nicolae A, Meeker H, Raffeld M, Xi L, Jegalian AG, et al. Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis. Am J Surg Pathol. 2015;39(12):1719\u201329.","journal-title":"Am J Surg Pathol"},{"key":"794_CR7","first-page":"14","volume":"8","author":"Y Yang","year":"2017","unstructured":"Yang Y, Wickless H. Thinking about CNS metastasis in cutaneous lymphoma: analysis of existing data. Leuk Res Rep. 2017;8:14\u20138.","journal-title":"Leuk Res Rep"},{"issue":"2","key":"794_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/his.13223","volume":"71","author":"T Miyata-Takata","year":"2017","unstructured":"Miyata-Takata T, Takata K, Kato S, Hu LM, Noujima-Harada M, Chuang SS, et al. Clinicopathological analysis of primary central nervous system NK\/T cell lymphoma: rare and localized aggressive tumour among extranasal NK\/T cell tumours. Histopathology. 2017;71(2):287\u201395.","journal-title":"Histopathology"},{"issue":"1","key":"794_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1182\/blood-2014-12-616961","volume":"126","author":"F Ellin","year":"2015","unstructured":"\u2022 Ellin F, Landstr\u00f6m J, Jerkeman M, Relander T. Central nervous system relapse in peripheral T-cell lymphomas: a Swedish lymphoma registry study. Blood. 2015;126(1):36\u201341 This is a large cohort using information from the Swedish Lymphoma Registry which clarifies risk factors for CNS relapse and progression, as well as overall outcome.","journal-title":"Blood"},{"issue":"7","key":"794_CR10","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/annonc\/mdq645","volume":"22","author":"JH Yi","year":"2011","unstructured":"Yi JH, Kim JH, Baek KK, Lim T, Lee DJ, Ahn YC, et al. Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma. Ann Oncol. 2011;22(7):1636\u201343.","journal-title":"Ann Oncol"},{"issue":"1","key":"794_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11899-018-0431-4","volume":"13","author":"D Chihara","year":"2018","unstructured":"\u2022 Chihara D, Oki Y. Central nervous system involvement in peripheral T cell lymphoma. Curr Hematol Malig Rep. 2018;13(1):1\u20136 This is a review that includes new data from a previously reported retrospective study identifying risk factors and survival outcome for CNS relapse of peripheral T-cell lymphoma in 600 patients, organized by histologic subtype.","journal-title":"Curr Hematol Malig Rep."},{"issue":"5","key":"794_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/0284186X.2015.1118656","volume":"55","author":"R Gurion","year":"2016","unstructured":"Gurion R, Mehta N, Migliacci JC, Zelenetz A, Moskowitz A, Lunning M, et al. Central nervous system involvement in T-cell lymphoma: a single center experience. Acta Oncol. 2016;55(5):561\u20136.","journal-title":"Acta Oncol"},{"issue":"1","key":"794_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/bjh.14402","volume":"176","author":"B Rubio-Gonzalez","year":"2017","unstructured":"Rubio-Gonzalez B, Zain J, Rosen ST, Querfeld C. Clinical manifestations and pathogenesis of cutaneous lymphomas: current status and future directions. Br J Haematol. 2017;176(1):16\u201336.","journal-title":"Br J Haematol"},{"issue":"4","key":"794_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410360411","volume":"36","author":"DK Kaufman","year":"1994","unstructured":"Kaufman DK, Habermann TM, Kurtin PJ, O'Neill BP. Neurological complications of peripheral and cutaneous T-cell lymphomas. Ann Neurol. 1994;36(4):625\u20139.","journal-title":"Ann Neurol"},{"issue":"1","key":"794_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/00130404-200601000-00010","volume":"12","author":"M Stein","year":"2006","unstructured":"Stein M, Farrar N, Jones GW, Wilson LD, Fox L, Wong RK, et al. Central neurologic involvement in mycosis fungoides: ten cases, actuarial risk assessment, and predictive factors. Cancer J. 2006;12(1):55\u201362.","journal-title":"Cancer J"},{"issue":"1","key":"794_CR16","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1016\/j.clml.2013.09.016","volume":"14","author":"G Zhao","year":"2014","unstructured":"Zhao G, Chamberlain MC, Khot SP, Shustov A, Olerud JE, Shinohara MM. Central nervous system involvement in cutaneous T-cell lymphoma: 2 illustrative cases and a review of current literature. Clin Lymphoma Myeloma Leuk. 2014;14(1):e25\u201330.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"794_CR17","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1001\/archopht.1977.04450040111017","volume":"95","author":"JL Keltner","year":"1977","unstructured":"Keltner JL, Fritsch E, Cykiert RC, Albert DM. Mycosis fungoides. Intraocular and central nervous system involvement. Arch Ophthalmol. 1977;95(4):645\u201350.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"794_CR18","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1111\/j.1524-4725.1990.tb00078.x","volume":"16","author":"ML Lindae","year":"1990","unstructured":"Lindae ML, Luy J, Abel EA, Kaplan R. Mycosis fungoides with CNS involvement: neuropsychiatric manifestations and complications of treatment with intrathecal methotrexate and whole-brain irradiation. J Dermatol Surg Oncol. 1990;16(6):550\u20133.","journal-title":"J Dermatol Surg Oncol"},{"issue":"2 Suppl 1","key":"794_CR19","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaad.2007.09.025","volume":"59","author":"BA Vu","year":"2008","unstructured":"Vu BA, Duvic M. Central nervous system involvement in patients with mycosis fungoides and cutaneous large-cell transformation. J Am Acad Dermatol. 2008;59(2 Suppl 1):S16\u201322.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"794_CR20","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","volume":"75","author":"JP Farcet","year":"1990","unstructured":"Farcet JP, Gaulard P, Marolleau JP, Le Couedic JP, Henni T, Gourdin MF, et al. Hepatosplenic T-cell lymphoma: sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood. 1990;75(11):2213\u20139.","journal-title":"Blood."},{"issue":"3","key":"794_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1365-2559.1998.00394.x","volume":"32","author":"A Lavergne","year":"1998","unstructured":"Lavergne A, Brocheriou I, Delfau MH, Copie-Bergman C, Houdart R, Gaulard PH. Primary intestinal gamma-delta T-cell lymphoma with evidence of Epstein-Barr virus. Histopathology. 1998;32(3):271\u20136.","journal-title":"Histopathology"},{"issue":"3","key":"794_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/ejh.12439","volume":"94","author":"M Foppoli","year":"2015","unstructured":"Foppoli M, Ferreri AJ. Gamma-delta t-cell lymphomas. Eur J Haematol. 2015;94(3):206\u201318.","journal-title":"Eur J Haematol"},{"issue":"9","key":"794_CR23","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1080\/10428190410001697368","volume":"45","author":"Y Harada","year":"2004","unstructured":"Harada Y, Kato S, Komiya H, Shirota T, Mukai K, Hayashi T. Primary omental gamma\/delta T-cell lymphoma involving the central nervous system. Leuk Lymphoma. 2004;45(9):1947\u201350.","journal-title":"Leuk Lymphoma"},{"key":"794_CR24","doi-asserted-by":"crossref","unstructured":"Jones N, Gibb A, Irion L, Coupland S. Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss. Case Reports 2017; 2017:bcr\u20132017\u2013219946.","DOI":"10.1136\/bcr-2017-219946"},{"issue":"12","key":"794_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/cup.12395","volume":"41","author":"L Harrington","year":"2014","unstructured":"Harrington L, Sokol L, Holdener S, Shao H, Zhang L. Cutaneous gamma-delta T-cell lymphoma with central nervous system involvement: report of a rarity with review of literature. J Cutan Pathol. 2014;41(12):936\u201343.","journal-title":"J Cutan Pathol"},{"key":"794_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jocn.2015.10.017","volume":"26","author":"KL Mooney","year":"2016","unstructured":"Mooney KL, Choy W, Woodard J, Xian RR, Deal TM, Kendle RF, et al. Primary central nervous system gamma delta cytotoxic T-cell lymphoma. J Clin Neurosci. 2016;26:138\u201340.","journal-title":"J Clin Neurosci"},{"issue":"6","key":"794_CR27","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/cncr.20502","volume":"101","author":"RS Go","year":"2004","unstructured":"Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer. 2004;101(6):1404\u201313.","journal-title":"Cancer"},{"issue":"1","key":"794_CR28","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3892\/ol.2016.4635","volume":"12","author":"Y Qiu","year":"2016","unstructured":"Qiu Y, Zhang D, Zhang M. Long-term remission of subcutaneous panniculitis-like T-cell lymphoma with central nervous system involvement: a case report. Oncol Lett. 2016;12(1):611\u20134.","journal-title":"Oncol Lett"},{"issue":"6","key":"794_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1159\/000108799","volume":"43","author":"IO Karikari","year":"2007","unstructured":"Karikari IO, Thomas KK, Lagoo A, Cummings TJ, George TM. Primary cerebral ALK-1-positive anaplastic large cell lymphoma in a child. Case report and literature review. Pediatr Neurosurg. 2007;43(6):516\u201321.","journal-title":"Pediatr Neurosurg"},{"issue":"9","key":"794_CR30","first-page":"647","volume":"197","author":"SS Chuang","year":"2001","unstructured":"Chuang SS, Huang W, Lin CN, Chio CC, Tsai TC, Li CY, et al. Primary cerebral anaplastic large cell lymphoma containing abundant reactive histiocytes and eosinophils. A case report and literature review. Pathol Res Pract. 2001;197(9):647\u201352.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"794_CR31","first-page":"55","volume":"11","author":"A Feldges","year":"1992","unstructured":"Feldges A, Gerhard L, Reinhardt V, Budach V. Primary cerebral anaplastic T-cell-lymphoma (type Ki-1): review and case report. Clin Neuropathol. 1992;11(2):55\u20139.","journal-title":"Clin Neuropathol"},{"issue":"2","key":"794_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1440-1789.2008.00935.x","volume":"29","author":"K Kodama","year":"2009","unstructured":"Kodama K, Hokama M, Kawaguchi K, Tanaka Y, Hongo K. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature. Neuropathology. 2009;29(2):166\u201371.","journal-title":"Neuropathology"},{"issue":"1","key":"794_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4274\/Tjh.2012.0028","volume":"31","author":"S G\u00f6\u00e7men","year":"2014","unstructured":"G\u00f6\u00e7men S, Kutlay M, Erik\u00e7i A, Atabey C, Sayan O, Haholu A. Central nervous system involvement of T-cell prolymphocytic leukemia diagnosed with stereotactic brain biopsy: case report. Turk J Haematol. 2014;31(1):75\u20138.","journal-title":"Turk J Haematol"},{"issue":"8","key":"794_CR34","first-page":"14207","volume":"8","author":"UY Malkan","year":"2015","unstructured":"Malkan UY, Gunes G, Yayar O, Demiroglu H, Yesilirmak A, Uner A. A T-cell prolymphocytic leukemia case with central nervous system involvement. Int J Clin Exp Med. 2015;8(8):14207\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"794_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/cncr.22032","volume":"107","author":"N Osuji","year":"2006","unstructured":"Osuji N, Matutes E, Tjonnfjord G, Grech H, Del Giudice I, Wotherspoon A, et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer. 2006;107(3):570\u20138.","journal-title":"Cancer"},{"issue":"7","key":"794_CR36","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00277-015-2360-9","volume":"94","author":"CY Cheung","year":"2015","unstructured":"Cheung CY, Ip AH, Iu PL, Lee EY, Kwong YL. Retinal and central nervous system involvement in T cell large granular lymphocyte leukaemia. Ann Hematol. 2015;94(7):1245\u20136.","journal-title":"Ann Hematol"},{"issue":"4","key":"794_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s11899-018-0458-6","volume":"13","author":"AA Phillips","year":"2018","unstructured":"Phillips AA, Harewood JCK. Adult T cell leukemia-lymphoma (ATL): state of the art. Curr Hematol Malig Rep. 2018;13(4):300\u20137.","journal-title":"Curr Hematol Malig Rep"},{"issue":"2\u20133","key":"794_CR38","first-page":"81","volume":"15","author":"Lymphoma Study Group (1984-1987)","year":"1991","unstructured":"Lymphoma Study Group (1984-1987). Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk Res. 1991;15(2\u20133):81\u201390.","journal-title":"Leuk Res"},{"issue":"6","key":"794_CR39","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/ijc.2910600617","volume":"60","author":"MS Pombo de Oliveira","year":"1995","unstructured":"Pombo de Oliveira MS, Matutes E, Schulz T, Carvalho SM, Noronha H, Reaves JD, et al. T-cell malignancies in Brazil. Clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. Int J Cancer. 1995;60(6):823\u20137.","journal-title":"Int J Cancer"},{"issue":"7","key":"794_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00234-002-0787-x","volume":"44","author":"M Kitajima","year":"2002","unstructured":"Kitajima M, Korogi Y, Shigematsu Y, Liang L, Matsuoka M, Yamamoto T, et al. Central nervous system lesions in adult T-cell leukaemia: MRI and pathology. Neuroradiology. 2002;44(7):559\u201367.","journal-title":"Neuroradiology"},{"issue":"2","key":"794_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/1097-0142(19900115)65:2<327::AID-CNCR2820650224>3.0.CO;2-W","volume":"65","author":"T Teshima","year":"1990","unstructured":"Teshima T, Akashi K, Shibuya T, Taniguchi S, Okamura T, Harada M, et al. Central nervous system involvement in adult T-cell leukemia\/lymphoma. Cancer. 1990;65(2):327\u201332.","journal-title":"Cancer"},{"issue":"2","key":"794_CR42","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/PAS.0000000000000109","volume":"38","author":"AC Hsi","year":"2014","unstructured":"Hsi AC, Kreisel FH, Frater JL, Nguyen TT. Clinicopathologic features of adult T-cell leukemias\/lymphomas at a North American tertiary care medical center: infrequent involvement of the central nervous system. Am J Surg Pathol. 2014;38(2):245\u201356.","journal-title":"Am J Surg Pathol"},{"key":"794_CR43","first-page":"917369","volume":"2014","author":"WL Ma","year":"2014","unstructured":"Ma WL, Li CC, Yu SC, Tien HF. Adult T-cell lymphoma\/leukemia presenting as isolated central nervous system T-cell lymphoma. Case Rep Hematol. 2014;2014:917369.","journal-title":"Case Rep Hematol"},{"issue":"17","key":"794_CR44","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1182\/blood-2008-10-185256","volume":"113","author":"WY Au","year":"2009","unstructured":"Au WY, Weisenburger DD, Intragumtornchai T, Nakamura S, Kim WS, Sng I, et al. Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009;113(17):3931\u20137.","journal-title":"Blood"},{"issue":"9","key":"794_CR45","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1200\/JCO.2015.63.5540","volume":"34","author":"SV Adams","year":"2016","unstructured":"Adams SV, Newcomb PA, Shustov AR. Racial patterns of peripheral T-cell lymphoma incidence and survival in the United States. J Clin Oncol. 2016;34(9):963\u201371.","journal-title":"J Clin Oncol"},{"issue":"1","key":"794_CR46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.1998.16.1.70","volume":"16","author":"MM Cheung","year":"1998","unstructured":"Cheung MM, Chan JK, Lau WH, Foo W, Chan PT, Ng CS, et al. Primary non-Hodgkin\u2019s lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998;16(1):70\u20137.","journal-title":"J Clin Oncol"},{"issue":"5","key":"794_CR47","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/annonc\/mdp412","volume":"21","author":"SJ Kim","year":"2010","unstructured":"\u2022 Kim SJ, Oh SY, Hong JY, Chang MH, Lee DH, Huh J, et al. When do we need central nervous system prophylaxis in patients with extranodal NK\/T-cell lymphoma, nasal type? Ann Oncol. 2010;21(5):1058\u201363 This paper attempted to identify risk factors for CNS invasion in extranodal natural killer (NK)\/T-cell lymphoma, nasal type. It provides some guidance for when to consider CNS prophylaxis in patients with this malignancy.","journal-title":"Ann Oncol"},{"issue":"1","key":"794_CR48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Cheng Y, Zhang M, Yan J, Li L, Fu X, et al. Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma. J Hematol Oncol. 2018;11(1):15.","journal-title":"J Hematol Oncol"},{"key":"794_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.wneu.2018.11.036","volume":"122","author":"Jonathan C. Lau","year":"2019","unstructured":"Lau JC, Kosteniuk SE, Walker T, Iansavichene A, Macdonald DR, Megyesi JF. Operative complications with and without image-guidance: a systematic review and meta-analysis of the Ommaya reservoir literature. World Neurosurg 2018;122(9):404\u2013414.","journal-title":"World Neurosurgery"},{"issue":"33","key":"794_CR50","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2015.63.1143","volume":"33","author":"N Schmitz","year":"2015","unstructured":"Schmitz N, Wu HS. Advances in the treatment of secondary CNS lymphoma. J Clin Oncol. 2015;33(33):3851\u20133.","journal-title":"J Clin Oncol"},{"issue":"33","key":"794_CR51","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1200\/JCO.2015.61.1236","volume":"33","author":"AJ Ferreri","year":"2015","unstructured":"Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M, Zambello R, et al. High doses of antimetabolites followed by high-dose sequential chemoimmunotherapy and autologous stem-cell transplantation in patients with systemic B-cell lymphoma and secondary CNS involvement: final results of a multicenter phase II trial. J Clin Oncol. 2015;33(33):3903\u201310.","journal-title":"J Clin Oncol"},{"issue":"9","key":"794_CR52","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1182\/blood-2014-10-604561","volume":"125","author":"A Omuro","year":"2015","unstructured":"Omuro A, Correa DD, DeAngelis LM, Moskowitz CH, Matasar MJ, Kaley TJ, et al. R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma. Blood. 2015;125(9):1403\u201310.","journal-title":"Blood"},{"issue":"23","key":"794_CR53","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2017-01-764209","volume":"129","author":"L Nayak","year":"2017","unstructured":"Nayak L, Iwamoto FM, LaCasce A, Mukundan S, Roemer MGM, Chapuy B, et al. PD-1 blockade with nivolumab in relapsed\/refractory primary central nervous system and testicular lymphoma. Blood. 2017;129(23):3071\u20133.","journal-title":"Blood"},{"issue":"17","key":"794_CR54","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","volume":"129","author":"YL Kwong","year":"2017","unstructured":"Kwong YL, Chan TSY, Tan D, Kim SJ, Poon LM, Mow B, et al. PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase. Blood. 2017;129(17):2437\u201342.","journal-title":"Blood"},{"issue":"6","key":"794_CR55","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s11899-018-0480-8","volume":"13","author":"P Ghione","year":"2018","unstructured":"Ghione P, Moskowitz AJ, De Paola NEK, Horwitz SM, Ruella M. Novel immunotherapies for T cell lymphoma and leukemias. Curr Hematol Malig Rep. 2018;13(6):494\u2013506.","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"794_CR56","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","volume":"12","author":"AD Zelenetz","year":"2014","unstructured":"Zelenetz AD, Gordon LI, Wierda WG, Abramson JS, Advani RH, Andreadis CB, et al. Non-Hodgkin\u2019s lymphomas, version 4.2014. J Natl Compr Cancer Netw. 2014;12(9):1282\u2013303.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"26","key":"794_CR57","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.1182\/blood-2010-02-266890","volume":"115","author":"B Pro","year":"2010","unstructured":"\u2022 Pro B, Perini G. Central nervous system prophylaxis in peripheral T-cell lymphoma. Blood. 2010;115(26):5427 A letter to the editor referencing data from M.D. Anderson Cancer Center on CNS relapse, arguing against the utility of CNS prophylaxis in these patients.","journal-title":"Blood"},{"issue":"6","key":"794_CR58","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/S1130-1473(09)70133-2","volume":"20","author":"J Gasco","year":"2009","unstructured":"Gasco J, Franklin B, Fuller GN, Salinas P, Prabhu S. Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report. Neurocirugia (Astur). 2009;20(6):550\u20134.","journal-title":"Neurocirugia (Astur)"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-019-0794-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-019-0794-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T10:59:36Z","timestamp":1659092376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-019-0794-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["794"],"URL":"https:\/\/doi.org\/10.1007\/s11912-019-0794-2","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"27 March 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"40"}}